How should I use this medicine?

COSENTYX (secukinumab) is indicated for various inflammatory conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and hidradenitis suppurativa.

Indications for COSENTYX

COSENTYX is a human interleukin-17A antagonist indicated for treating moderate to severe plaque psoriasis in patients aged 6 years and older, active psoriatic arthritis in patients aged 2 and older, and adults with ankylosing spondylitis, non-radiographic axial spondyloarthritis, and moderate to severe hidradenitis suppurativa. Additionally, it is used in pediatric patients with enthesitis-related arthritis (ERA) aged 4 years and older. Its application extends to conditions with inflammatory involvement, providing significant therapeutic benefits across a range of autoimmune disorders.